http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1212149-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_404c787d6b2e4d3f135ee391f79199a0
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-096
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C205-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C205-26
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C205-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C205-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-096
filingDate 1969-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1970-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1212149-A
titleOfInvention p-AMINOARYLALKANOL DERIVATIVES AND THE PREPARATION THEREOF
abstract 1,212,149. Heterocyclic derivatives of 2-(paminoaryl) ethanol. E. MERCK A.G. 26 June, 1969 [1 Aug., 1968], No. 32342/69. Heading C2C. The invention comprises compounds of formula wherein R<SP>1</SP> is OH (which may be esterified or etherified), R<SP>2</SP> is H, Me or Et, R<SP>3</SP> is F, Cl, Br, I, NO 2 , NH 2 , Me, Et, MeS when R<SP>4</SP> and R<SP>5</SP> are H, or R<SP>3</SP> is H when R<SP>4</SP>, R<SP>5</SP> together form -CH=CH-CH=CH-, and Q is pyrrolidino, piperidino or homopiperidino; and their acid addition and quaternary ammonium salts. Standard preparative methods are used. Specified intermediates corresponding with the above formula are prepared, which may have (a) instead of the -CHR<SP>2</SP>CH<SP>2</SP>R<SP>1</SP> group: CHMeCOCl, C(: CH 2 )COCl, CHMeCHO, CHR<SP>2</SP>CO 2 R<SP>2</SP>, CMe: CHOMe, CHClCH 2 OMe, CMe 2 OH, COCH 2 Br, CHMeCO 2 CO 2 Et, CHR<SP>2</SP>CH 2 Br, CMe: CH 2 , COCH 2 OMe, CHOHCH 2 OH, CHMeOH, C(: CH 2 )CH 2 OMe, C(OH)MeCH 2 OMe, Ac, CMeCH 2 O, CHMeCON 3 , CHMeCONHNH 2 , CHMeCH 2 NH 2 ; and/or (b) instead of R<SP>3</SP>: CN, Ac or SH, or instead of R<SP>4</SP>R<SP>5</SP>: -(CH 2 ) 4 - or H for R<SP>3</SP>, R<SP>4</SP>, R<SP>5</SP>; and/or (c) instead of Q: Br, NH 2 , MeCONH, Br(CH 2 ) 4 CONH or 2-(hydroxy, methoxy or oxo) piperidino. Also prepared is 2-(3-chloro-4- piperidinophenyl) propyl carbonate. Therapeutic compositions for parenteral, enteral or topical application comprise compounds of the above formula, which have antiphlogistic, analgesic, antipyretic, bacteriostatic, bactericidal, antiprotozoal, diuretic, hypoglycaemic, choleretic, hypocholesterolaemic and antiradiation activity.
priorityDate 1968-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457655803
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396227
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410

Total number of triples: 21.